Clinical Need


Addressing Unmet Challenges


 Bilitech’s Regenerative Medicine Solutions break new ground into a previously unexploited £8bn market


350,000 new cases per annum with bile duct diseases

75,000 new cases per annum with disease affecting large ducts amenable to surgical replacement

275,000 new cases per annum with diffuse disease affecting small ducts not amenable to surgery

Minimal treatment options other than surgery or a liver transplantation

Accounting for 30% of adult and 70% of paediatric liver transplantation

Contact Us